Medicine & health
In 2020, AlphaFold2 solved a 50-year-old problem: predicting a protein’s 3-D structure from its amino-acid sequence. Its predictions now cover virtually all ~200 million known proteins and are used by 2–3 million researchers in 190 countries, supporting work on disease, antibiotic resistance and drug discovery. Independent analysis links its use to a ~40% increase in submissions of novel experimental protein structures, and AlphaFold-linked research is about twice as likely to be cited in clinical articles.